Nephrology

"A big revolution is coming in ultrasound," says Dr. Clément Papadacci from Inserm

Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease

Finerenone vs Placebo in Type 1 Diabetes and CKD: Updates From the Phase 3 FINE-ONE Trial From the Kidney Meeting 2025 in Houston

Implications of the FINE-ONE Trial: How Might Recently Presented Data From the 2025 Kidney Meeting Influence the Current Treatment Paradigm for Type 1 Diabetes and CKD?

New Data From the CONFIDENCE Trial: The Effect of Combination Empagliflozin and Finerenone on UACR and eGFR in CKD and Type 2 Diabetes

The Role of APRIL and the 4-Hit Process in the Pathogenesis of IgA Nephropathy

Navigating IgA Nephropathy: Pathogenesis, The Role Of APRIL & The 4-Hit Process, & A Patient Case Study

Expert Opinions on Characteristics of Patients With C3G at High Risk of Progression

Expert Opinions on Characteristics of Patients With IgA Nephropathy (IgAN) at High Risk of Progression

Expert Opinions on Renal Compensation and Renal Functional Reserve